Virpax Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Virpax Pharmaceuticals has a total shareholder equity of $1.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $9.6M and $7.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$9.14m |
Equity | US$1.93m |
Total liabilities | US$7.69m |
Total assets | US$9.63m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: VRPX's short term assets ($9.6M) exceed its short term liabilities ($7.7M).
Long Term Liabilities: VRPX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: VRPX is debt free.
Reducing Debt: VRPX currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VRPX has sufficient cash runway for 11 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: VRPX is forecast to have sufficient cash runway for 10 months based on free cash flow estimates, but has since raised additional capital.